academic article

• Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase..  International journal of oncology.  49:487-98. 2016
• Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells..  Molecular cancer research : MCR.  10:1597-606. 2012